Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? A meta-analysis
Background and Aims. The combination of inhaled corticosteroids (ICS) and long-acting β2 agonists (LABA) has been used as a single inhaler both for maintenance and reliever therapy in asthma, the SMART approach. The administration of additional CS with each reliever inhalation in response to symptom...
Main Authors: | R. Agarwal, A. Khan, A.N. Aggarwal, D. Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2016-01-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/348 |
Similar Items
-
EARLY PRESCRIPTION OF INHALATION CORTICOSTEROID IN BRONCHIAL ASTHMA
by: Z. R. Aisanov, et al.
Published: (2017-11-01) -
Maintenance Therapy for Children and Adolescents with Asthma: Guidelines and Recommendations from the Emilia-Romagna Asthma (ERA) Study Group
by: Valentina Fainardi, et al.
Published: (2023-08-01) -
ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy
by: Álvaro A. Cruz, et al.
Published: (2021-01-01) -
Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
by: Masato Muraki, et al.
Published: (2017-01-01) -
Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
by: Richard Beasley, et al.
Published: (2019-12-01)